Display options
Cite
Liu R, Wang YH, Tang Y, et al. Effect of octreotide on cell-cycle kinetics and serum carcinoembryonic antigen level in hepatic metastases of colonic adenocarcinoma. World J Gastroenterol. 1997;3(2):69-71doi: 10.3748/wjg.v3.i2.69.
Liu, R., Wang, Y. H., Tang, Y., & Cao, G. S. (1997). Effect of octreotide on cell-cycle kinetics and serum carcinoembryonic antigen level in hepatic metastases of colonic adenocarcinoma. World journal of gastroenterology, 3(2), 69-71. https://doi.org/10.3748/wjg.v3.i2.69
Liu, R, et al. "Effect of octreotide on cell-cycle kinetics and serum carcinoembryonic antigen level in hepatic metastases of colonic adenocarcinoma." World journal of gastroenterology vol. 3,2 (1997): 69-71. doi: https://doi.org/10.3748/wjg.v3.i2.69
Liu R, Wang YH, Tang Y, Cao GS. Effect of octreotide on cell-cycle kinetics and serum carcinoembryonic antigen level in hepatic metastases of colonic adenocarcinoma. World J Gastroenterol. 1997 Jun 15;3(2):69-71. doi: 10.3748/wjg.v3.i2.69. PMID: 27041941; PMCID: PMC4801926.
Copy Download .nbib Format: NLM
Share it on

World J Gastroenterol. 1997 Jun 15;3(2):69-71. doi: 10.3748/wjg.v3.i2.69.

Effect of octreotide on cell-cycle kinetics and serum carcinoembryonic antigen level in hepatic metastases of colonic adenocarcinoma.

World journal of gastroenterology

R Liu, Y H Wang, Y Tang, G S Cao

Affiliations

  1. Rui Liu, Yuan-He Wang, Yan Tang, Gui-Song Cao, Department of Surgery, Changhai Hospital, Shanghai 200433, China.

PMID: 27041941 PMCID: PMC4801926 DOI: 10.3748/wjg.v3.i2.69

Abstract

AIM: To study the inhibitory effect of somatostatin analogue (octreotide) on tumor growth.

METHODS: The influence of cell-cycle kinetics on hepatic metastases of BALB/c mice colonic adenocarcinoma (CT26) with octreotide treatment in vivo was investigated by flow cytometry. The serum carcinoembryonic antigen (CEA) levels were also determined.

RESULTS: The results showed that the proliferative index (PI) and the S-phase fraction in hepatic tumors of mice treated with octreotide decreased markedly and that the G0/G1 serum CEA phase fraction increased significantly in comparison with the control (P < 0.01). After administration of octreotide, the serum CEA levels were also lower than those in the control group. The incidence of liver metastases in the treated group was lower than that in the control. The body weight loss in the mice was slower and survival was longer in the treated group than in the control group. Furthermore, the changes in PI and the fraction distribution of S-phase or G0/G1-phase in cell cycle were closely related to the serum CEA levels.

CONCLUSION: Octreotide may be useful for inhibiting the hepatic metastases of colonic carcinoma.

Keywords: Carcinoembryonic antigen/analysis; Colonic neoplasms; Cytometry; Liver neoplasms/secondary; Octreotide; adenocarcinoma

References

  1. Cancer Res. 1986 Mar;46(3):1015-29 - PubMed
  2. Cancer Res. 1988 Dec 15;48(24 Pt 1):6977-85 - PubMed
  3. Br J Surg. 1994 Sep;81(9):1333-7 - PubMed
  4. Immunol Today. 1987;8(10):298-303 - PubMed
  5. Int J Cancer. 1992 Nov 11;52(5):791-6 - PubMed
  6. J Surg Res. 1991 Mar;50(3):245-51 - PubMed
  7. Cell. 1989 Apr 21;57(2):327-34 - PubMed
  8. Cancer. 1993 Jul 1;72(1):244-8 - PubMed
  9. J Natl Cancer Inst. 1990 Mar 7;82(5):380-5 - PubMed
  10. Br J Cancer. 1995 Jan;71(1):97-101 - PubMed

Publication Types